Genprex, Inc.
Support and Resistance Levels
Past performance
News About GNPX
All events for GNPX
All deals for GNPX
Financial Ratios
Financial Statements
GNPX vs Sector & Peers
About Genprex, Inc.
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas. Website genprex.com
Headquarters Austin, TX, US